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Although microbiologists have been ringing the alarm bell for years, the threat of drug (antibiotic) resistance has reached new prominence in the popular press that the issue should be added to the list of global emergencies. [1] [2] [3] [4] [5] [6] It is now indisputable that drug resistance is lifethreatening in the same sense as cancer, both in the number of cases and the likely outcome. 5 According to a recent report released by the United States Centers for Disease Control and Prevention (CDC), each year in the United States, over 2 million people acquire serious drug-resistant infections. 7 At least 23,000 people die each year as a direct result of drug-resistant infections. 7 Many more die from other conditions that are complicated by a drug-resistant infection. In addition, drugresistant infections add considerable and avoidable costs to the already overburdened healthcare system. In most cases, drug-resistant infections require prolonged and/or costlier treatments, extend hospital stays, necessitate additional doctor visits and healthcare use, and result in greater morbidity and mortality compared with infections that are easily treatable with antibiotics. The estimated total economic cost of drug resistance to the United States economy have ranged as high as $20 billion in excess direct healthcare costs, with additional costs to society for lost productivity as high as $35 billion a year. 7 The extensive use of antibiotics is the single most important factor leading to drug resistance. [7] [8] [9] There is consequently a critical need for the development of new therapeutics to tackle drug resistance., 5, [10] [11] [12] In 2014, the White House announced the National Strategy for Combating Antibiotic-Resistant Bacteria. 13 One of the 5 goals for action by the United States government, as outlined in the National Strategy, is to "Accelerate basic and applied research and development for new antibiotics, other therapeutics, and vaccines". 13 A novel light-based approach, antimicrobial blue light (aBL), has attracted increasing attention due to its intrinsic antimicrobial effect without the involvement of exogenous photosensitizers. [14] [15] [16] [17] [18] [19] [20] [21] [22] The mechanism of action of aBL is still not fully understood. A common hypothesis is that aBL excites naturally occurring endogenous photosensitizes (iron-free porphyrins or/and flavins) within microbial cells and subsequently leads to the production of cytotoxic oxidative species. 14, 23 Studies have demonstrated that aBL was effective in inactivating a wide range of important pathogenic microbes regardless of their drug-resistance profiles, including Gram-negative bacteria, Gram-positive bacteria, yeasts and molds in either planktonic or biofilm forms. [14] [15] [16] [17] 21, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] Endogenous photosensitizing porphyrins and flavins with the peak absorption of light at 405 and 470 nm, respectively, were identified in microbial cells. 14, 23, 25, 26, 30, 35 It was also observed that pathogenic microbes are less able to develop resistance to aBL than to conventional antibiotics. Our group recently performed several studies by exposing Pseudomonas aeruginosa, 25 Acinetobacter baumannii, 28 Candida albicans 27 or Escherichia coli (unpublished), to repeated cycles of sub-lethal aBL. No development of aBL resistance was observed after 10-20 cycles of repeated aBL exposures. 25, 27, 28 Other studies demonstrated that aBL did not cause significant damages to host cells and did not impair wound healing. 18, 26, 28, 34, 39, 40 In this issue of Virulence, Fila et al. 22 investigated the effectiveness of aBL inactivation of Pseudomonas aeruginosa using a panel of wide types and clinical strains, including multidrug-resistant and extensively drug-resistant strains. In agreement of previous studies, the authors found that aBL exerted significant antimicrobial effect on all Pseudomonas aeruginosa strains tested, resulting in 5.2-to 8-log 10 reduction of colony forming units (CFU). More importantly, 2 other unique findings relevant to the mechanism behind the antimicrobial effect of aBL were revealed in the study of Fila and his colleagues. First, it was found that lethal aBL exposures inactivated multiple virulence factors of P. aeruginosa. Second, it was observed that sublethal aBL exposures increased the susceptbility of P. aeruginosa to muiltiple antibiotics, i.e., the synergistic effect of aBL and antibitocs. 22 The ability of pathogenic microbes to cause disease in a host is determined by multiple virulence factors acting individually or together at different stages of infections. 41 Even after the successful inactivation of a pathogenic microbe, virulence factors may still be present and cause significant damage to host tissues. Moreover, several studies have shown an increase in the production and activity of virulence factors after exposure to different antibiotics. 42, 43 As a result, the approaches that inhibit the production, delivery and activity of virulence factors are of significant interests. In this study, Fila and his colleagues reported the first time that lethal aBL exposures at 405-nm (exposures that induced >3-log 10 CFU inactivation) inactivated multiple virulence factors of P. aeruginosa including both cell-associated determinates and numerous secreted factors, indicating that aBL targeted the pathogenic mechanism of P. aeruginosa. It is suggested that aBL inactivation of virulence factors is due to the activity of reactive oxygen species (ROS) generated during photodynamic process. ROS interacts with various biomolecules, leading to their destruction. 22 The ability of aBL inactivation of virulence factors of pathogens renders aBL an advantageous approach over conventional antibiotics. Of note, the authors also found that sub-lethal aBL exposures (0.5-2-log 10 inactivation of CFU) did not affect the production and activity of virulence factors.
Although sub-lethal aBL exposures demonstrated no effect on the production and activity of virulence factors, the authors reported the first time that the exposure of P. aeruginosa to sub-lethal aBL increased the susceptibility of P. aeruginosa to different antibiotics (gentamycin, ceftazidime and meropenem), a phenomenon called hypersusceptibility. After being pretreated with a sub-lethal aBL exposure of 12.5 J/cm 2 , the minimum inhibitory concentration values of P. aeruginosa were 2-, 8-and even 64-fold lower. 22 The mechanism behind the aBLinduced hyper-susceptibility to antibiotics is worth further investigation. One of the principle mechanisms of drug resistance in P. aeruginosa is the low permeability of its cell wall. 44, 45 In the studies of our laboratory, we observed via transmission electron microscopy that sublethal exposures of aBL induced cell wall damage in microbes. 27, 30 This may enhance the penetration of antibiotics into microbial cells and subsequently potentiate the inactivation of microbes. Another possibility leading to aBL-induced hyper-susceptibility to antibiotics is the oxidative stress-induced under-expression of drug resistance genes. A few other studies reported the synergistic effect of antimicrobial photodynamic therapy (aPDT) and antibiotics on biofilms. It was observed that aPDT induced disruption of biofilm protective matrix involving microbial cells, thus rendering biofilms more susceptible to antibiotics. [46] [47] [48] [49] An important benefit of combination therapies using multiple approaches (e.g., aBL C antibiotic) is that they may reduce the development of drug resistance, because of the multi-target characteristic of combination therapies. 50 In the future study, it would be also of interest to investigate the effect of the combination therapy with aBL and antibiotics on the virulence factors of pathogenic microbes.
This study was only limited to P. aeruginosa in planktonic form, as was already realized by the authors. However, it provided valuable insights into the mechanisms behind the antimicrobial effect of blue light and gave the implications for investigating the interaction between aBL and other important pathogens in either planktonic or biofilm forms.
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